“…In accordance with this observation, the use of cefepime increased the sensitivity of the DDST for the detection of ESBLs in Enterobacter from 16 to 61% when the disks were applied at the standard distance of 30 mm from clavulanate, and from 71 to 90% with closer application of the disks [61]. [14,16,63,64] VEB, GES/IBC, KPC E. cloacae [62,65,80,81,83,84,116] NMC-A, IMI-1, IMI-2 E. cloacae, Enterobacter asburiae [74][75][76][77][78][79]82] Ambler class B VIM E. cloacae, Enterobacter ludwigii [55,89,92] IMP, NDM-1 E. cloacae [86][87][88]90,91,96,97] Ambler class C Amp-C, ACT-1 E. cloacae, E. asburiae, E. hormaechei, Enterobacter kobei [57,113] Ambler class D OXA-48 E. cloacae [98,101] Fluoroquinolones Plasmid-mediated quinolone resistance Acetyltransferase AAC(6´)-Ib-cr E. cloacae [108,109,111,116] Qnr-mediated topoisom protection…”